Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/105538
Title: | Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes |
Author: | Nakagawa, Kenji Gonzalez Roca, Eva Souto, Alejandro Kawai, Toshinao Umebayashi, Hiroaki Campistol Plana, Jaume Cañellas, Jeronima Takei, Syuji Kobayashi, Norimoto Callejas Rubio, José Luis Ortego Centeno, Norberto Ruiz Ortiz, Estíbaliz Rius, Fina Antón López, Jordi Iglesias Jiménez, Estíbaliz Jiménez Treviño, Santiago Vargas, Carmen Fernandez Martin, Julian Calvo, Inmaculada Hernández Rodríguez, José Méndez, María Dordal, María Teresa Basagaña, Maria Buján Rivas, Segundo Yashiro, Masato Kubota, Tetsuo Koike, Ryuji Akuta, Naoko Shimoyama, Kumiko Iwata, Naomi Saito, Megumu K. Ohara, Osamu Kambe, Naotomo Yasumi, Takahiro Izawa, Kazushi Kawai, Tomoki Heike, Toshio Yagüe, Jordi Nishikomori, Ryuta Aróstegui Gorospe, Juan Ignacio |
Keywords: | Genètica molecular Malalties hereditàries Genètica mèdica Inflamació Molecular genetics Genetic diseases Medical genetics Inflammation |
Issue Date: | Mar-2015 |
Publisher: | BMJ Publishing Group |
Abstract: | Familial cold autoinflammatory syndrome, Muckle-Wells syndrome (MWS), and chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome are dominantly inherited autoinflammatory diseases associated to gain-of-function NLRP3 mutations and included in the cryopyrin-associated periodic syndromes (CAPS). A variable degree of somatic NLRP3 mosaicism has been detected in ≈35% of patients with CINCA. However, no data are currently available regarding the relevance of this mechanism in other CAPS phenotypes. OBJECTIVE: To evaluate somatic NLRP3 mosaicism as the disease-causing mechanism in patients with clinical CAPS phenotypes other than CINCA and NLRP3 mutation-negative. METHODS: NLRP3 analyses were performed by Sanger sequencing and by massively parallel sequencing. Apoptosis-associated Speck-like protein containing a CARD (ASC)-dependent nuclear factor kappa-light chain-enhancer of activated B cells (NF-κB) activation and transfection-induced THP-1 cell death assays determined the functional consequences of the detected variants. RESULTS: A variable degree (5.5-34.9%) of somatic NLRP3 mosaicism was detected in 12.5% of enrolled patients, all of them with a MWS phenotype. Six different missense variants, three novel (p.D303A, p.K355T and p.L411F), were identified. Bioinformatics and functional analyses confirmed that they were disease-causing, gain-of-function NLRP3 mutations. All patients treated with anti-interleukin1 drugs showed long-lasting positive responses. CONCLUSIONS: We herein show somatic NLRP3 mosaicism underlying MWS, probably representing a shared genetic mechanism in CAPS not restricted to CINCA syndrome. The data here described allowed definitive diagnoses of these patients, which had serious implications for gaining access to anti-interleukin 1 treatments under legal indication and for genetic counselling. The detection of somatic mosaicism is difficult when using conventional methods. Potential candidates should benefit from the use of modern genetic tools |
Note: | Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2013-204361 |
It is part of: | Annals of the Rheumatic Diseases, 2015, vol. 74, num. 3, p. 603-610 |
URI: | http://hdl.handle.net/2445/105538 |
Related resource: | https://doi.org/10.1136/annrheumdis-2013-204361 |
ISSN: | 0003-4967 |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
640866.pdf | 1.25 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.